Agilent | A - Current Assets

Stock Price
132.14
Daily Change
-3.25 -2.40%
Monthly
-7.55%
Yearly
-10.13%
Q1 Forecast
129.73

Agilent reported $4.59B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 24.84B 371M Sep/2025
Agilent USD 4.59B 341M Sep/2025
Align Technology USD 2.53B 86.04M Sep/2025
Bio Techne USD 609.51M 1.21M Sep/2025
Bio-Rad Laboratories USD 2.84B 30.9M Sep/2025
Bruker USD 2.35B 187.9M Sep/2025
Charles River Laboratories USD 1.53B 62.24M Sep/2025
Danaher USD 12.76B 3.15B Dec/2025
Dentsply International USD 2.07B 106M Sep/2025
Edwards Lifesciences USD 6.36B 218.3M Sep/2025
Exact Sciences USD 1.59B 82.87M Sep/2025
Henry Schein USD 4.4B 152M Sep/2025
Hologic USD 3.84B 175.3M Dec/2025
Illumina USD 2.8B 155M Sep/2025
Intuitive Surgical USD 12.4B 927.3M Dec/2025
IQVIA Holdings USD 5.98B 366M Sep/2025
Laboratory Of America USD 4.08B 8.4M Sep/2025
Mettler Toledo International USD 1.28B 36.74M Sep/2025
Myriad Genetics USD 344.8M 60.5M Sep/2025
Quest Diagnostics USD 2.41B 209M Sep/2025
Quidel USD 1.37B 85.2M Sep/2025
Repligen USD 1.1B 39.62M Sep/2025
Revvity USD 2.14B 92.4M Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Waters USD 1.92B 137.07M Sep/2025
Zimmer Biomet Holdings USD 5.83B 781M Sep/2025